India’s largest drug maker by market capitalization Sun Pharma on Wednesday said that it will pay Pfizer and Japanese drug maker Takeda $550 million jointly to settle a patent infringement suit in the US on generic pantoprazole, an anti-acidity...
India’s Sun Pharmaceuticals and Israel’s Teva will pay a sum of $2.15 billion to Pfizer and Takeda as part of patent infringement settlement for acid reflux medicine Protonix in the US.“Und...
Last month, Millennium CEO Deborah Dunsire stepped down and company veteran Anna Protopapas stepped in as president of the company, which will no longer operate as autonomously as it had before the reorganization. The reorganization will also come...
Takeda Pharmaceutical Company Limited (OTC: TKPYY) today announced interim
data from a Phase 1/2, open-label, multicenter study with ADCETRIS®
(brentuximab vedotin) in pediatric patients diagnosed with CD30-positive
relapsed...
Amag Pharmaceuticals and partner Takeda have run into a snag in Switzerland. Japan-based Takeda is recalling a batch of Amag's anemia drug Feraheme, sold as Rienso in the Swiss market, after several reports of hypersensitivity reactions, one...
CEO Deborah Dunsire is retiring from Millennium, the unit Takeda bought about 5 years ago, as Millennium's oncology R&D is rolled up into the parent company's global research organization.